Skip to main content
 

Main menu

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Archives
    • Most-Read Papers of 2022
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2023 Call for Abstracts
    • 2022 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
American Association for Respiratory Care
  • Subscribe
  • My alerts
  • Log in
American Association for Respiratory Care

Advanced Search

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Archives
    • Most-Read Papers of 2022
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2023 Call for Abstracts
    • 2022 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal
  • Twitter
  • Facebook
  • YouTube
EditorialEditorials

Should Noninvasive Ventilation Be Used in End-Stage Chronic Respiratory Failure to Reverse Hypercapnic Coma?

John D Davies
Respiratory Care September 2019, 64 (9) 1169; DOI: https://doi.org/10.4187/respcare.07337
John D Davies
Respiratory Care Services Duke University Hospital Durham, North Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Info & Metrics
  • References
  • PDF
Loading

In this issue of Respiratory Care, Lemyze and colleagues1 conducted a prospective, observational, case–control study of the use of noninvasive ventilation (NIV) in 43 subjects who were classified as do not intubate (DNI) and were experiencing hypercapnic coma resulting from end-stage chronic respiratory failure. This group was compared to a cohort of 43 frail subjects with end-stage hypercapnic respiratory failure but without hypercapnic coma. The investigators found that NIV was usually successful in both groups in reversing hypercapnia and more than half survived > 6 months after the acute event. Also, upon being surveyed, most surviving subjects said they would choose to be placed on NIV if a new episode of acute hypercapnic respiratory failure occurred.

This study highlights a topic that is controversial. The use of NIV in patients with chronic irreversible respiratory disease who experience an acute event has gained some support, but there remain clinicians who will not prescribe it. These clinicians argue that NIV adds to patients' discomfort and that it delays the dying process.2 This reasoning would be valid if this strategy were applied to a heterogeneous population. However, it has been shown that patients with acute on chronic respiratory failure (especially COPD) who receive NIV may have a decent chance of surviving an acute hypercarbic event.3 In this patient population, there is be some component of reversibility in which NIV will be beneficial. However, it is difficult to assess reversibility without an NIV trial. The study by Lemyze and colleagues1 adds to this body of evidence and suggests that at least a trial of NIV is warranted in the patient population experiencing an acute event.

The pH levels in Lemyze's study ranged from 7.06 to 7.21 (mean 7.15) in the hypercapnic coma group. A pH level < 7.25 has been previously reported to be an important prognostic indicator.4 However, recent work by Steriade et al5 did not identify a connection for mortality between a pH level < 7.15 and NIV. Guidelines from the British Thoracic Society/Intensive Care Society state that severe acidosis should not preclude a trial of NIV for an exacerbation of COPD.6 From this literature, it's fair to say that patients with COPD who are suffering from an acute event that results in hypercapnic coma should be offered a trial of NIV. However, clear end points in the event of NIV failure must be established with caregivers and family members in terms of what will constitute NIV failure (eg, lack of coma reversal in a specified length of time) and specifically what will be done once the NIV is discontinued.

In summary, patients with chronic irreversible respiratory failure experiencing an acute respiratory failure event should be offered a trial of NIV. If the NIV proves to be successful, these patients may return to their baseline functionality level and continue their lives. However, clear end points must be established in the event of NIV failure so as not to unduly delay the dying process.

Footnotes

  • Correspondence: John D Davies MA RRT FAARC, Duke University Health System, Box 3911, DUH, Durham, NC 27710. E-mail: john.davies{at}duke.edu.
  • Mr Davies discloses a relationship with Teleflex Medical.

  • See the Original Study on Page 1023

  • Copyright © 2019 by Daedalus Enterprises

References

  1. 1.↵
    1. Lemyze M,
    2. De Palleja G,
    3. Guiot A,
    4. Bury Q,
    5. Jonard M,
    6. Mallat J
    . Outcome of frail do-not-intubate subjects with end-stage chronic respiratory failure and their opinion regarding noninvasive ventilation to reverse hypercapnic coma. Respir Care 2019;64(9):1023–1030.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Clarke DE,
    2. Vaughan L,
    3. Raffin TA
    . Noninvasive positive pressure ventilation for patients with terminal respiratory failure: the ethical and economic costs of delaying the inevitable are too great. Am J Crit Care 1994;3(1):4–5.
    OpenUrlPubMed
  3. 3.↵
    1. Wilson ME,
    2. Majzoub AM,
    3. Dobler CC,
    4. Curtis JR,
    5. Nayfeh T,
    6. Thorsteinsdottir B,
    7. et al
    . Noninvasive ventilation in patients with do-not-intubate and comfort-measures-only orders: a systematic review and meta-analysis. Crit Care Med 2018;46(8):1209–1216.
    OpenUrl
  4. 4.↵
    1. Confalonieri M,
    2. Garuti G,
    3. Cattaruzza MS,
    4. Osborn JF,
    5. Antonelli M,
    6. Conti G,
    7. et al
    . A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J 2005;25(2):348–355.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Steriade AT,
    2. Johari S,
    3. Sargarovschi N,
    4. Necula D,
    5. Tudose CE,
    6. Ionita D,
    7. et al
    . Predictors of outcome of noninvasive ventilation in severe COPD exacerbation. BMC Pulm Med 2019;19:131.
    OpenUrl
  6. 6.↵
    1. Davidson AC,
    2. Banham S,
    3. Elliott M,
    4. Kennedy D,
    5. Gelder C,
    6. Glossop A,
    7. et al
    . BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. Thorax 2016;71:ii1–ii35.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Respiratory Care: 64 (9)
Respiratory Care
Vol. 64, Issue 9
1 Sep 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author

 

Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Association for Respiratory Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Should Noninvasive Ventilation Be Used in End-Stage Chronic Respiratory Failure to Reverse Hypercapnic Coma?
(Your Name) has sent you a message from American Association for Respiratory Care
(Your Name) thought you would like to see the American Association for Respiratory Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Should Noninvasive Ventilation Be Used in End-Stage Chronic Respiratory Failure to Reverse Hypercapnic Coma?
John D Davies
Respiratory Care Sep 2019, 64 (9) 1169; DOI: 10.4187/respcare.07337

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Should Noninvasive Ventilation Be Used in End-Stage Chronic Respiratory Failure to Reverse Hypercapnic Coma?
John D Davies
Respiratory Care Sep 2019, 64 (9) 1169; DOI: 10.4187/respcare.07337
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Info For

  • Subscribers
  • Institutions
  • Advertisers

About Us

  • About the Journal
  • Editorial Board

AARC

  • Membership
  • Meetings
  • Clinical Practice Guidelines

More

  • Contact Us
  • RSS
American Association for Respiratory Care

Print ISSN: 0020-1324        Online ISSN: 1943-3654

© Daedalus Enterprises, Inc.

Powered by HighWire